Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 21 March 2012 | By Alexander Gaffney, RAC
Life sciences manufacturer Johnson & Johnson sold its now-controversial vaginal mesh implant for three years prior to being approved by the US Food and Drug Administration (FDA) in 2008, reports Bloomberg.
The unauthorized sale of the Prolift vaginal mesh implant product, manufactured by Johnson & Johnson's Ethicon unit, could place the 510(k) approval pathway under additional scrutiny.
The company marketed Prolift as early as 2005, reports Bloomberg, reasoning that it was substantially equivalent to the already-approved Gynecare Gynemesh.
FDA "disagreed with this assertion," said FDA press officer Morgan Liscinsky, when FDA learned of the device in 2007, but still approved the product under the 510(k) pathway in 2008.
The company is currently embroiled in hundreds of lawsuit over the devices, which plaintiffs claim caused injury to them. The revelation about the unapproved sales of Prolift, could make it considerably harder to settle or win some of the lawsuit, said Bloomberg.
Bloomberg - J&J Sold Vaginal Mesh Implant Without U.S. Regulatory Approval
Tags: Prolift, Vaginal Mesh, Bloomberg, J&J, Lawsuit, Implant, Johnson & Johnson, Latest News, 510(k), medical device
Regulatory Focus newsletters
All the biggest regulatory news and happenings.